{"id":"NCT02607306","sponsor":"Novo Nordisk A/S","briefTitle":"A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Japanese Subjects With Type 2 Diabetes Mellitus.","officialTitle":"A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Japanese Subjects With Type 2 Diabetes Mellitus","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-11-18","primaryCompletion":"2017-12-15","completion":"2017-12-22","firstPosted":"2015-11-18","resultsPosted":"2019-07-29","lastUpdate":"2021-04-09"},"enrollment":819,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Diabetes","Diabetes Mellitus, Type 2"],"interventions":[{"type":"DRUG","name":"insulin degludec/liraglutide","otherNames":[]},{"type":"DRUG","name":"insulin degludec","otherNames":[]},{"type":"DRUG","name":"liraglutide","otherNames":[]}],"arms":[{"label":"Insulin degludec/liraglutide OD","type":"EXPERIMENTAL"},{"label":"Insulin degludec OD","type":"ACTIVE_COMPARATOR"},{"label":"Liraglutide OD","type":"ACTIVE_COMPARATOR"}],"summary":"This trial is conducted in Asia. The aim of this trial is to compare the efficacy and safety of insulin degludec/liraglutide, insulin degludec and liraglutide in Japanese subjects with type 2 diabetes mellitus.","primaryOutcome":{"measure":"Change From Baseline in HbA1c (Glycosylated Haemoglobin) Tested for Non-inferiority of IDegLira vs IDeg and Superiority of IDegLira vs Lira","timeFrame":"Week 0, Week 52","effectByArm":[{"arm":"Insulin Degludec/Liraglutide","deltaMin":-2.42,"sd":1.04},{"arm":"Insulin Degludec","deltaMin":-1.8,"sd":1.02},{"arm":"Liraglutide","deltaMin":-1.8,"sd":0.92}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"},{"comp":"OG000 vs OG002","p":"<0.0001"}]},"eligibility":{"minAge":"20 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":9},"locations":{"siteCount":76,"countries":["Japan"]},"refs":{"pmids":["31407845","33595901"],"seeAlso":["http://novonordisk-trials.com"]},"adverseEventsSummary":{"seriousAny":{"events":17,"n":275},"commonTop":["Viral upper respiratory tract infection","Constipation","Diarrhoea","Diabetic retinopathy","Nausea"]}}